Methapharm Inc 2023-05-03 Health serious FDA
Health · FDA · Recall #FDA-D-0540-2023
Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous… Recall
Issued May 3, 2023 · Methapharm Inc
In May 2023, Methapharm Inc recalled the Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
What you should do
- 1 Stop using Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Methapharm Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Methapharm Inc
- Category
- Health
- Recall date
- May 3, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0540-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Methapharm Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.